Congress Archives - Newcells Biotech

Newcells Biotech

Newcells Biotech Win Phase II of CRACK IT Challenge 29: ImmuLiver

Newcells hiPSC lung models; Valuable tools in understanding health impacts of air pollution

Newcells Biotech acquires IP for Retinal Organoids from Newcastle University

Vision for the Future of Childhood Retinal Dystrophies

Newcells Biotech Ltd. RPE Model to Improve Drug Retinal Toxicity Assessment

Dr Frank Armstrong appointed as Non-executive Director

iPSC derived retinal organoids: A Promising Tool for Modelling Retinitis Pigmentosa

Newcells Biotech technology: the fight against antibacterial resistance

Newcells Biotech Win Phase I of CRACK IT Challenge 29: ImmuLiver – Securing £99,711 Funding

Looking Forward: A Year in Review

BY Newcells Biotech

November 9, 2018

ESTIV 2018 International Congress

Congress Round-Up The International Congress on in vitro Toxicology (ESTIV2018) organised by the European Society of Toxicology was held in Berlin this October 2018. This year marks its 20th meeting, with the general theme of new approach methodologies

BY Newcells Biotech

June 15, 2018June 15, 2018

17th Annual World Preclinical Congress – Boston, MA (18th-21st June)

If you are attending the World Preclinical Congress and would like to arrange a meeting with Dr Colin Brown, then please let us know.